yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q36230808-008364EC-D9EE-4EB2-80C6-F498CC80CC32
Q36230808-008364EC-D9EE-4EB2-80C6-F498CC80CC32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36230808-008364EC-D9EE-4EB2-80C6-F498CC80CC32
Adoptive cellular therapy enhances the helper T cell response and reduces the number of regulatory T cells.
P2860
Q36230808-008364EC-D9EE-4EB2-80C6-F498CC80CC32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36230808-008364EC-D9EE-4EB2-80C6-F498CC80CC32
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
73078650f9eecca3079bff8d88c50a20a6661dc0
P2860
A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.